Unclogging the Downstream Bottlenecks in Bioprocessing
After upstream bioprocessing, such as developing a cell line or microorganism that can produce an intended product, a bioprocessor turns to downstream steps to capture and purify that product, as well as subjecting it...
A Noble Pursuit: Biotech Pioneers Remembered
The death of William (Bill) Rutter at the grand old age of 97 in July reminded me to remember not only him, but several of the other pioneers of our industry—lest we should forget...
Innovative topical cream relieves chemotherapy-induced peripheral neuropathy
Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment. Addressing this unmet clinical need,...
New study explains how pathogenic bacteria digest ethanolamine
A new study, led by researchers at the University of Liverpool, has revealed how pathogenic bacteria construct tiny protein-based compartments, known as Eut microcompartments, which enable them to digest ethanolamine - a nutrient commonly...
Scientists discover new protein family regulating motility and DNA uptake
Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire network of RNA-protein interactions inside human cells - an achievement that could offer new strategies...
“Human REPAIRome“ Catalogues 20,000 DNA Scar Patterns After Double-Stranded Breaks
You can always be judged by your scars. This is the idea that sums up what researchers at Spanish National Cancer Research Centre (CNIO) claim is one of the new breakthroughs in basic and...
The World Vaccine Congress heads to Amsterdam, where it will draw experts and leaders...
Industry leaders and experts from across the globe will meet in Amsterdam to discuss advancements in research and development processes within the evolving vaccine industry. The event will address 12 important and varied tracks...
Kinetics Matter in Degrader Design
Sponsored content brought to you by
Since their introduction in 2001, proteolysis-targeting chimeras (PROTACs) and other degrader compounds have reshaped the drug discovery landscape by targeting previously “undruggable” proteins. Unlike traditional inhibitors that block protein...
Revvity Launches AI Software Offering for Preclinical Imaging
Revvity launched its Living Image Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities, and...
Tissue-mimicking hydrogels drive cell reprogramming via matrix remodeling
The mechanical properties of tissue matrix are crucial for maintaining cell health and function. With aging, tissue matrix loses its mechanical integrity and exhibits altered biophysical properties, which are closely associated with various diseases...
